Advertisement
  • A Treatment That Came Just in Time

    Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

    by Laurie Adami

  • Putting the Patient in the Driver’s Seat

    In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond.

    by Kevin McLaughlin

  • Expanding Immunotherapy

    At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.

    by Kevin McLaughlin

  • Making Connections at the AACR Annual Meeting 2021

    Attending a scientific conference as a patient advocate can be an exhausting, overwhelming and hugely rewarding experience.

    by Bradley Jones

  • Chemobrain: It’s Not Your Imagination

    Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

    by Marci A. Landsmann

  • A Drive for Diversity

    African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

    by Jon Kelvey

  • Patient Advocates Tune in for Precision Medicine Primer

    Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.

    by Kevin McLaughlin

  • Living Beyond a Diagnosis

    Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.

    by Judy Pearson

  • Physicians Underestimate Severity of Radiation Side Effects

    Breast cancer patients' symptoms after radiation therapy may go underrecognized, especially if these patients are Black or younger in age.

    by Marci A. Landsmann

  • Taking Drug Dosing Off Autopilot

    Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life.

    by Marcus A. Banks

Advertisement